What are the side effects of Diltiazem (a calcium channel blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diltiazem can cause several side effects, including hypotension, bradycardia, and precipitation of heart failure, as noted in the 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care 1.

Common Side Effects

The most frequent side effects of diltiazem include:

  • Hypotension (low blood pressure)
  • Bradycardia (slow heart rate)
  • Precipitation of heart failure
  • Dizziness
  • Headache
  • Peripheral edema (swelling in the ankles and feet)

Serious Side Effects

More concerning side effects of diltiazem include:

  • Heart block
  • Liver dysfunction
  • Skin rashes
  • Gingival hyperplasia (overgrowth of gum tissue)

Special Considerations

Elderly patients are particularly susceptible to the hypotensive effects of diltiazem, as noted in the 2013 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction 1.

Recommendations

Diltiazem should be used with caution in patients with heart failure, pre-excited AF or flutter, or rhythms consistent with VT, and should only be given to patients with narrow-complex tachycardias (regular or irregular) 1. In addition, diltiazem can have a detrimental effect on mortality rates in patients with LV dysfunction, as noted in the 2013 ACCF/AHA focused update 1. The 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia also recommends that diltiazem be avoided in patients with advanced heart failure and in patients with heart block or sinus node dysfunction in the absence of pacemaker therapy 1.

From the FDA Drug Label

ADVERSE REACTIONS Serious adverse reactions have been rare in studies carried out to date, but it should be recognized that patients with impaired ventricular function and cardiac conduction abnormalities usually have been excluded In domestic placebo-controlled angina trials, the incidence of adverse reactions reported during diltiazem hydrochloride therapy was not greater than that reported during placebo therapy. The following represent occurrences observed in clinical studies of angina patients. In many cases, the relationship to diltiazem hydrochloride has not been established The most common occurrences from these studies, as well as their frequency of presentation, are edema (2.4%), headache (2.1%), nausea (1.9%), dizziness (1.5%), rash (1.3%), and asthenia (1. 2%) In addition, the following events were reported infrequently (less than 1%): Cardiovascular: Angina, arrhythmia, AV block (first-degree), AV block (second- or third-degree – see WARNINGS, Cardiac Conduction), bradycardia, bundle branch block, congestive heart failure, ECG abnormality, flushing, hypotension, palpitations, syncope, tachycardia, ventricular extrasystoles Nervous System: Abnormal dreams, amnesia, depression, gait abnormality, hallucinations, insomnia, nervousness, paresthesia, personality change, somnolence, tremor Gastrointestinal: Anorexia, constipation, diarrhea, dysgeusia, dyspepsia, mild elevations of alkaline phosphatase, SGOT, SGPT, and LDH (see WARNINGS, Acute Hepatic Injury), thirst, vomiting, weight increase elevation, dry mouth, dyspnea, epistaxis, eye irritation, hyperglycemia, hyperuricemia, impotence, muscle cramps, nasal congestion, nocturia, osteoarticular pain, polyuria, sexual difficulties, tinnitus The following postmarketing events have been reported infrequently in patients receiving diltiazem hydrochloride tablets: acute generalized exanthematous pustulosis, allergic reactions, alopecia, angioedema (including facial or periorbital edema), asystole, erythema multiforme (including Stevens-Johnson syndrome, toxic epidermal necrolysis), extrapyramidal symptoms, gingival hyperplasia, hemolytic anemia, increased bleeding time, leukopenia, photosensitivity (including lichenoid keratosis and hyperpigmentation at sun-exposed skin areas), purpura, retinopathy, myopathy, and thrombocytopenia

The common side effects of Diltiazem include:

  • Edema (2.4%)
  • Headache (2.1%)
  • Nausea (1.9%)
  • Dizziness (1.5%)
  • Rash (1.3%)
  • Asthenia (1.2%) The less common side effects include:
  • Cardiovascular events such as angina, arrhythmia, and hypotension
  • Nervous system events such as abnormal dreams, depression, and insomnia
  • Gastrointestinal events such as anorexia, constipation, and diarrhea
  • Other events such as alopecia, angioedema, and photosensitivity 2

From the Research

Diltiazem Side Effects

  • Diltiazem, a non-dihydropyridine calcium channel blocker, can cause side effects such as conduction disturbances and heart failure in patients with underlying cardiac disease 3.
  • The use of diltiazem may be associated with a decreased risk of heart failure hospitalization, but also with an increased risk of all-cause mortality compared to beta blockers 4.
  • Diltiazem can cause sinus arrest or severe sinus bradycardia, especially when used in combination with beta-blockers 5.
  • Diltiazem has been shown to improve cardiac performance and reduce systemic vascular resistance, but may also cause a decrease in heart rate 6.
  • As a calcium channel blocker, diltiazem is commonly used in the treatment of hypertension, but may be less effective than other agents in preventing heart failure and myocardial infarction 7.

Common Side Effects

  • Conduction disturbances
  • Heart failure
  • Sinus arrest or severe sinus bradycardia
  • Decrease in heart rate
  • Peripheral edema (less common with newer agents)

Special Considerations

  • Patients with underlying cardiac disease should be monitored closely for signs of conduction disturbances and heart failure 3.
  • The combination of diltiazem and beta-blockers should be used with caution due to the increased risk of sinus arrest or severe sinus bradycardia 5.
  • Diltiazem may be suitable for patients with comorbid Raynaud's syndrome, isolated systolic hypertension, or angina pectoris 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Calcium channel blockers.

AACN clinical issues in critical care nursing, 1992

Research

Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 2004

Research

The role of existing and newer calcium channel blockers in the treatment of hypertension.

Journal of clinical hypertension (Greenwich, Conn.), 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.